Results 1 - 1 of 1

Efficacy and safety of a novel tetravalent dengue vaccine in healthy children aged 2 to 14 years in Asia

HERDIN record number :
NCR-RITM-14032710142946
Author(s) :
Company Sanofi Pasteur
Source Document :
Abstract :
Sanofi Pasteur is developing a chimeric yellow fever-dengue vaccine (CYD). The USAMRMC has adopted CYD into USAMMDA's Advanced Development Program. The study aims to assess the efficacy of CYD dengue vaccine after 3 vaccinations at 0, 6, and 12 months in preventing symptomatic virologically-confirme . . .
Physical Location :
US National Library of Medicine
Fulltext Availability :
Not available

Results 1 - 1 of 1